-
Kenya's economy faces climate change risks: World Bank
-
Italy's Po River valley on drought alert
-
Southern Europe 'becoming more flammable' in hotter climate, experts say
-
Prada profits pinched as growth hard to chase
-
Mammoth bones found on parched bed of Danube in Bulgaria
-
Stocks climb on earnings and rates, oil retreats
-
MEXC Lists Grvt (GRVT) with $60,000 Worth of GRVT and 10,000 USDT in Airdrop+ Rewards
-
US economic growth slows in second quarter, missing expectations
-
George and Amal Clooney flee French home due to wildfire
-
Russia adds Telegram founder Durov to 'terrorist' blacklist
-
MEXC Ventures Supports Alpha Arena's APAC Debut at Coinfest Bali
-
Stocks diverge on earnings, as oil steadies
-
AI data centre supplier Zhongji InnoLight slips on Hong Kong debut
-
Eurozone economy grows despite Middle East war
-
May, June heatwaves caused 2,877 extra deaths in England: govt
-
Singapore group will develop 'most promising' Ebola vaccine
-
BMW profit down a third as carmaker plans job cuts
-
Shell profit surges as Mideast war fuels oil prices
-
Seoul extends losses as most Asian markets drop, oil rises again
-
Car maker Stellantis says back in profit in second quarter
-
Gambling.com Group Is Now Grandstand
-
Samsung quarterly operating profit up 1,800% on AI boom
-
Meet the astronomer digging into the Milky Way's 'fossils'
-
South Korean stocks bounce after rout, oil holds gains on Mideast woes
-
AI data centre supplier Zhongji InnoLight falls on Hong Kong debut
-
South Korea's women web sleuths fight AI deepfake porn
-
Samsung operating profit up 1,800% in second quarter on AI boom
-
Anything but programmable: New cost-efficient EC-power-supply-series for the DIN rail by CAMTEC PS
-
Japanese population below 120 million for first time in decades
-
Meta misses profit expectations, sticks to massive AI spending
-
US actor Jared Leto denies latest accusations of sexual assault
-
Campari - king of the spritz - hopes to conquer American heartland
-
Danube drops to 'historic lows' as fresh heatwave hits
-
Air France-KLM and Lufthansa bid for Portugal's TAP airline
-
BTS pulls out of Grammys after Asian pop category introduction
-
Profits soar at Airbus as it delivers more planes
-
OpenAI says rogue AI agent attack hit other companies
-
Rheinmetall shares surge after armsmaker reports record profit
-
How an AFP beach snap became emblem of Europe's wildfire summer
-
FIFA hit by furious backlash over plans to sell stake in competitions
-
TRX Spot and Perpetuals Listing Launches on Backpack, Expanding Access to the TRON Ecosystem
-
MEXC Integrates World-Check to Fortify Institutional Grade Compliance Architecture
-
Nepal's tiger numbers climb 20 percent to estimated 429: survey
-
Spain returns wildfire evacuees as France braces for worsening weather
-
FIFA's plans to sell $4.2bn stake in its tournaments widely criticised
-
Russia seeks arrest of Telegram chief Durov
-
BMW aims to cut 8,000 jobs by end 2027: company source
-
South Korean stocks plunge as tech rout deepens, oil rises
-
On London streets, homeless wary at PM's vow to end rough sleeping
-
UBS says second-quarter net profit up 17% to $2.8 billion
'Ketamine Queen' to plead guilty over drugs that killed Matthew Perry
A dealer dubbed the "Ketamine Queen" has agreed to plead guilty to supplying the drugs that killed "Friends" actor Matthew Perry, the US Department of Justice said Monday.
Jasveen Sangha, 42, will admit several charges, including one of distribution of ketamine resulting in death or serious bodily injury in relation to the late star.
Sangha, who is expected to formally enter her pleas in the coming weeks, is a dual citizen of the United States and the United Kingdom. She has been in federal custody since August 2024.
She will become the fifth person to admit playing a part in the death of the beloved actor, who had openly struggled for decades with substance addiction.
Perry was found dead in the hot tub of his Los Angeles home in 2023 at the age of 54.
A criminal investigation was launched soon after an autopsy discovered he had high levels of ketamine -- an anesthetic -- in his system.
Last month Dr Salvador Plasencia pleaded guilty to four counts of distribution of ketamine in the weeks before Perry's death.
Another doctor, Mark Chavez, admitted last year to conspiring to distribute ketamine to Perry.
Plasencia allegedly bought ketamine off Chavez and sold it to the American-Canadian actor at hugely inflated prices.
"I wonder how much this moron will pay," Plasencia wrote in one text message.
According to her plea agreement, Sangha worked with a middleman, Erik Fleming, to sell 51 vials of ketamine to Perry's live-in personal assistant, Kenneth Iwamasa.
Iwamasa repeatedly injected Perry with the ketamine that Sangha supplied, including on October 28, 2023, when he administered at least three shots of Sangha's ketamine, which killed the actor.
The Department of Justice said when she heard news reports about Perry's sudden death, Sangha tried to cover her tracks.
"Delete all our messages," she instructed Fleming.
Perry had been taking ketamine as part of supervised therapy for depression.
But prosecutors say that before his death he became addicted to the substance, which also has psychedelic properties and is a popular party drug.
"Friends," which followed the lives of six New Yorkers navigating adulthood, dating and careers, drew a massive following and made megastars of previously unknown actors.
Perry's role as the sarcastic man-child Chandler brought him fabulous wealth, but hid a dark struggle with addiction to painkillers and alcohol.
In 2018, he suffered a drug-related burst colon and underwent multiple surgeries.
In his 2022 memoir "Friends, Lovers and the Big Terrible Thing," Perry described going through detox dozens of times.
"I have mostly been sober since 2001," he wrote, "save for about sixty or seventy little mishaps."
X.Cheung--CPN